Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Retained Earnings (2016 - 2025)

Medifast (MED) has disclosed Retained Earnings for 16 consecutive years, with $158.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 87827.22% year-over-year to $158.3 million, compared with a TTM value of $158.3 million through Dec 2025, up 87827.22%, and an annual FY2025 reading of $158.3 million, up 87827.22% over the prior year.
  • Retained Earnings was $158.3 million for Q4 2025 at Medifast, down from $176.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $203.1 million in Q1 2022 and bottomed at $22000.0 in Q1 2024.
  • Average Retained Earnings over 5 years is $90.8 million, with a median of $130.4 million recorded in 2022.
  • The sharpest move saw Retained Earnings surged 254988.57% in 2021, then crashed 99.98% in 2024.
  • Year by year, Retained Earnings stood at $111000.0 in 2021, then surged by 125892.79% to $139.9 million in 2022, then grew by 24.88% to $174.6 million in 2023, then plummeted by 99.9% to $180000.0 in 2024, then soared by 87827.22% to $158.3 million in 2025.
  • Business Quant data shows Retained Earnings for MED at $158.3 million in Q4 2025, $176.2 million in Q3 2025, and $179000.0 in Q2 2025.